11-34919551-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003477.3(PDHX):​c.160+2736C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.222 in 152,128 control chromosomes in the GnomAD database, including 4,918 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.22 ( 4918 hom., cov: 33)

Consequence

PDHX
NM_003477.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.176

Publications

7 publications found
Variant links:
Genes affected
PDHX (HGNC:21350): (pyruvate dehydrogenase complex component X) The pyruvate dehydrogenase (PDH) complex is located in the mitochondrial matrix and catalyzes the conversion of pyruvate to acetyl coenzyme A. The PDH complex thereby links glycolysis to Krebs cycle. The PDH complex contains three catalytic subunits, E1, E2, and E3, two regulatory subunits, E1 kinase and E1 phosphatase, and a non-catalytic subunit, E3 binding protein (E3BP). This gene encodes the E3 binding protein subunit; also known as component X of the pyruvate dehydrogenase complex. This protein tethers E3 dimers to the E2 core of the PDH complex. Defects in this gene are a cause of pyruvate dehydrogenase deficiency which results in neurological dysfunction and lactic acidosis in infancy and early childhood. This protein is also a minor antigen for antimitochondrial antibodies. These autoantibodies are present in nearly 95% of patients with the autoimmune liver disease primary biliary cirrhosis (PBC). In PBC, activated T lymphocytes attack and destroy epithelial cells in the bile duct where this protein is abnormally distributed and overexpressed. PBC eventually leads to cirrhosis and liver failure. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Oct 2009]
PDHX Gene-Disease associations (from GenCC):
  • Leigh syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • pyruvate dehydrogenase E3-binding protein deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.332 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003477.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PDHX
NM_003477.3
MANE Select
c.160+2736C>G
intron
N/ANP_003468.2
PDHX
NM_001135024.2
c.-21+3065C>G
intron
N/ANP_001128496.2
PDHX
NM_001166158.2
c.160+2736C>G
intron
N/ANP_001159630.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PDHX
ENST00000227868.9
TSL:1 MANE Select
c.160+2736C>G
intron
N/AENSP00000227868.4
PDHX
ENST00000448838.8
TSL:5
c.-21+3065C>G
intron
N/AENSP00000389404.3
PDHX
ENST00000430469.6
TSL:2
c.160+2736C>G
intron
N/AENSP00000415695.2

Frequencies

GnomAD3 genomes
AF:
0.222
AC:
33780
AN:
152010
Hom.:
4917
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0703
Gnomad AMI
AF:
0.554
Gnomad AMR
AF:
0.192
Gnomad ASJ
AF:
0.252
Gnomad EAS
AF:
0.00250
Gnomad SAS
AF:
0.127
Gnomad FIN
AF:
0.241
Gnomad MID
AF:
0.206
Gnomad NFE
AF:
0.336
Gnomad OTH
AF:
0.233
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.222
AC:
33783
AN:
152128
Hom.:
4918
Cov.:
33
AF XY:
0.214
AC XY:
15911
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.0702
AC:
2915
AN:
41514
American (AMR)
AF:
0.192
AC:
2935
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.252
AC:
873
AN:
3470
East Asian (EAS)
AF:
0.00270
AC:
14
AN:
5188
South Asian (SAS)
AF:
0.128
AC:
619
AN:
4828
European-Finnish (FIN)
AF:
0.241
AC:
2550
AN:
10560
Middle Eastern (MID)
AF:
0.221
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
0.336
AC:
22822
AN:
67976
Other (OTH)
AF:
0.230
AC:
486
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1265
2530
3794
5059
6324
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
350
700
1050
1400
1750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.154
Hom.:
343
Bravo
AF:
0.214
Asia WGS
AF:
0.0600
AC:
207
AN:
3472

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
9.3
DANN
Benign
0.73
PhyloP100
0.18
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7479823; hg19: chr11-34941098; API